Corniche Hospital, a flagship hospital under the SEHA network and part of PureHealth, announced a groundbreaking milestone in ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

You are braver than you believe, stronger than you seem, smarter than you think, and twice as beautiful as you’d ever imagined. Cancer remains one of the most formidable health challenges ...

Laparoscopic Gynecological Procedures MarketThe global laparoscopic gynecological procedures market is projected to grow from USD 30 billion in 2024 to USD 61.3 billion by 2034, expanding at a CAGR of ...

M42 group’s Danat Al Emarat Hospital for Women & Children has entered a partnership with UK-based ProFaM to provide reproductive health services. The partnership will involve conducting ovarian tissue ...

Initially offered as an elective service, OTC will also be integrated into laparoscopic procedures, such as surgeries for endometriosis. Abu Dhabi Biobank is a key partner for this engagement which ...

[60] Therefore, except in cases of extreme pain or ovarian endometriomas that hinder oocyte retrieval, endometriomas can be managed expectantly. No OE or endometriosis (group 2) 162 11.9 ± 0.8 ...

One of the project teams that won funding from ARPA-H in late 2024 aims to develop a drug that would extend ovarian function throughout a woman’s lifespan. Similar pharmaceutical strategies are ...

In 2023, the global reusable laparoscopic instruments market is expected to be worth USD 3.8 billion. The market is expected to reach USD 6.3 billion by 2033, expanding at a 5.1% CAGR throughout the ...

and ovarian cancer (13.3% to 37.0%; AAPC, 9.4%); however, the use of laparoscopy for cervical cancer fluctuated, peaking at 69.7% in 2017 before declining to 49.9% in 2020. Sentinel lymph node ...